3rd Quarter - Report

TARPLIN, DOWNS & YOUNG, LLC for PHRMA

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

PL 114-255 - 21st Century Cures, implementation S. 771 - Improving Access to Affordable Prescription Drugs Act S. 637 - Creating Transparency to Have Drug Rebates Unlocked Act of 2017 Stopping the Pharmaceutical Industry From Keeping Drugs Expensive Act of 2017 S. 456 - RACE for Children Act S. 469 - Affordable and Safe Prescription Drug Importation act H.R. 749 - Lower Drug Costs Through Competition Act H.R. 878/S. 204 - Right to Try Act of 2017 H.R. 1480/S. 64/S. 92 - Safe and Affordable Drugs from Canada Act H.R. 1628 - American Health Care Act H.R. 2430 - FDA Reauthorization Act of 2017 Better Care Reconciliation Act of 2017 Graham-Cassidy Amendment no specific bills, 340B, Innovation, Transparency, Precision Medicine, NIH, Importation, Non-Interference, Vaccines, Biosimilars, Compounding

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
CHARLOTTE SPEARS IVANCIC —
ELIZABETH T MURRAY —
PAMELA SMITH —
JENNIFER B YOUNG —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 469 (115th), H.R. 1628 (115th), H.R. 878 (115th), S. 771 (115th), H.R. 2430 (115th), S. 456 (115th), S. 637 (115th), S. 64 (115th), H.R. 1480 (115th), S. 204 (115th), S. 92 (115th), H.R. 749 (115th)

Budget/Appropriations BUD

budget resolution, reconciliation, deficit reduction, debt ceiling, appropriations H.R. 244 - Consolidated Appropriations Act of 2017 S.Con.Res. 25 - Senate budget resolution H.Res. 553 - House budget resolution

LobbyistCovered position, as disclosed
RAISSA H DOWNS Prin. Dep. Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Staff Dir., Sub. Cmte. on Employment, Sen. HELP Cmte.
MICHELLE P EASTON Chief Health Counsel, Sen. Cmte. on Finance; Staff Dir., Senate Aging Cmte.; Leg. Asst., Congressman Billy Tauzin
CHARLOTTE SPEARS IVANCIC Legislative Counsel, Senator Jim DeMint; Health Counsel, Majority Leader Bill Frist; Counsel and Budget Analyst, House Budget Committee; Asst. to the Speaker for Policy, Speaker John Boehner
ELIZABETH T MURRAY Senior Policy Advisor, Democratic Whip Steny Hoyer; Legislative Asst. for Rep. Mike Thompson, Rep. Bob Matsui, and Senator Bob Graham
PAMELA SMITH Leg. Dir., Sen. Tom Harkin; Dep. Staff Dir., Senate HELP Cmte; Staff Dir., Senate HELP Cmte; Counselor to the Asst. AG, Civil Div., Dept of Justice; Spec Counsel, Ofc of Leg. Affairs, Dept of Justice; Counsel and LA, Senator Carol Moseley-Braun
JENNIFER B YOUNG Asst. Sec. for Leg. - HHS; Dep. Asst. Sec. for Leg. - HHS; Cmte. Staff, House Cmte. on Ways and Means; Cmte. Staff, Sen. Cmte. on Finance

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 244 (115th), H.Res. 553 (115th), S.Con.Res. 25 (115th)

Medicare/Medicaid MMM

S. 870 - Chronic Care S. 251 - Protecting Medicare from Executive Action of 2017 H.R. 849/S. 260 - Protecting Seniors' Access to Medicare Act of 2017 H.R. 242/S. 41 - Medicare Prescription Drug Price Negotiation Act of 2017 S. 348 - Prescription Drug and Health Improvement Act of 2017 H.R. 1316 - Prescription Drug Price Transparency Act H.J.Res. 51/S.J.Res. 16 - IPAB discontinuation H.R. 3921 - Healthy Kids Act S. 1827 - Kids Act of 2017 ***, no specific bill(s), Medicare and Medicaid Drug Reimbursement, Medicaid Rebate, dual eligibles, Sunshine, discount cards, MedPAC, biosimilars, Alternative Payment Models, Value based Purchasing, coding, CMMI, Part B, Part D, non-interference, IPAB

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
CHARLOTTE SPEARS IVANCIC —
ELIZABETH T MURRAY —
PAMELA SMITH —
JENNIFER B YOUNG —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 242 (115th), H.R. 1316 (115th), S. 41 (115th), H.R. 849 (115th), S. 348 (115th), S. 260 (115th), S. 870 (115th), S. 1827 (115th), S. 251 (115th), H.J.Res. 51 (115th), H.R. 3921 (115th), S.J.Res. 16 (115th)

Pharmacy PHA

PL 114-255 - 21st Century Cures, implementation H.R. 1628 - American Health Care Act of 2017 Better Care Reconciliation Act of 2017 Graham-Cassidy Amendment ***, no specific bill(s), prescription drug importation, import safety, supply chain integrity, Prescription Drug User Fee Act Fee Reauthorization and associated policies, user fee sequester, innovation

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
CHARLOTTE SPEARS IVANCIC —
ELIZABETH T MURRAY —
PAMELA SMITH —
JENNIFER B YOUNG —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1628 (115th)

Copyright/Patent/Trademark CPT

Patent reform

LobbyistCovered position, as disclosed
RAISSA H DOWNS —
MICHELLE P EASTON —
CHARLOTTE SPEARS IVANCIC —
ELIZABETH T MURRAY —
PAMELA SMITH —
JENNIFER B YOUNG —

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.